The latest version of the Good Clinical Practice (GCP) quality standard insists that sponsors implement a risk-based approach to study execution, a methodology that is now widely referred to as “RBx.”
CluePoints is dedicated to revolutionizing clinical trials through AI, advanced statistics, and machine learning. Aligned with global regulatory guidance, our holistic risk-based approach is designed to drive positive outcomes. Ready to uncover the clues and pinpoint success in your next trial? Contact our expert team today.
